Researcher Feature: Anne Knisely, MD

Anne Knisely, MD, of University of Texas MD Anderson Cancer Center, is the FWC 2023-2024 recipient of The St. Louis Ovarian Cancer Awareness and Caring Together Research Grant for Ovarian Cancer.

In this video, Dr. Knisely discusses her research objectives, including ovarian cancer cell resistance chemotherapy that could potentially improve patient outcomes.

“The main objective of the grant is to understand why these particular cells that are left behind after initial treatment are so resistant to chemotherapy, so I think the main impact would be understanding that and then seeing what those cells might be vulnerable to and then selecting certain novel therapeutic options to target that disease phase,” said Dr. Knisely.